NOTICIES
CRG Researchers collaborate in the identification of the genetic base of familial hypertension. The results of their work, conclude that mutations in a gene cause the majority of cases of a rare...
Sharing scientific expertise and know-how to explore new ways to evaluate translational medicine from basic research to patient benefits.
CRG scientists have described the mechanism that causes neuronal death in Huntington's chorea. The discovery will advance the development of therapeutic treatments for this rare disease.
EMBL PRESS RELEASE
MAKING THE MOST OF WHAT YOU HAVE
Bacterium fine-tunes proteins for enhanced functionality
CRG has a new research programme which will focus on the study of the mechanisms controlling gene expression and how these mechanisms may map out the cell fate.
Bringing together European excellence to uncover the mechanisms at work that determine cell fate. Comprising 8 academic institutions, 3 biotech companies and 1 pharmaceutical company, the EU...
New European network to train early stage researchers in cutting edge areas of neuroscience. The project will join efforts from eight academic centers and three industrial partners to promote...
The study coordinated by the CRG reproduced the same morphological and functional patterns of neuronal connections in a transgenic mouse as seen in people with Down’s syndrome. Regulating the...
- The investigator receives the award for his research in 2011 on gene expression.
The researchers Pedro Carvalho and Fyodor Kondrashov have received the "International Early Career Award" from the Howard Hughes Medical Institute (HHMI). The prize was presented to 28 candidates...